[1]
Ahmad, A. and Rehman, M. 2022. COMPARATIVE EVALUATION OF INTRAVITREAL DICLOFENAC PLUS BEVACIZUMAB VERSUS BEVACIZUMAB ALONE IN THE TREATMENT OF NAÏVE DIABETIC MACULAR EDEMA: A RANDOMIZED CONTROLLED TRIAL. KHYBER MEDICAL UNIVERSITY JOURNAL. 14, 4 (Dec. 2022), 228–33. DOI:https://doi.org/10.35845/kmuj.2022.22708.